San Francisco hep B free: a grassroots community coalition to prevent hepatitis B and liver cancer.
San Francisco hep B free: a grassroots community coalition to prevent hepatitis B and liver cancer.
复制标题
DOI:
10.1007/s10900-010-9339-1
复制
发表时间:
2011-08
影响因子:
5.9
通讯作者:
Chang, Ellen T.
中科院分区:
文献类型:
--
作者:
Bailey, Meredith B.;Shiau, Rita;Zola, Janet;Fernyak, Susan E.;Fang, Ted;So, Samuel K. S.;Chang, Ellen T.
关键词:
Chronic hepatitis B is the leading cause of liver cancer and the largest health disparity between Asian/Pacific Islanders (APIs) and the general US population. The Hep B Free model was launched to eliminate hepatitis B infection by increasing hepatitis B awareness, testing, vaccination, and treatment among APIs by building a broad, community-wide coalition. The San Francisco Hep B Free campaign is a diverse public/private collaboration unifying the API community, health care system, policy makers, businesses, and the general public in San Francisco, California. Mass-media and grassroots messaging raised citywide awareness of hepatitis B and promoted use of the existing health care system for hepatitis B screening and follow-up. Coalition partners reported semi-annually on activities, resources utilized, and system changes instituted. From 2007 to 2009, over 150 organizations contributed approximately $1,000,000 in resources to the San Francisco Hep B Free campaign. 40 educational events reached 1,100 healthcare providers, and 50% of primary care physicians pledged to screen APIs routinely for hepatitis B. Community events and fairs reached over 200,000 members of the general public. Of 3,315 API clients tested at stand-alone screening sites created by the campaign, 6.5% were found to be chronically infected and referred to follow-up care. A grassroots coalition that develops strong partnerships with diverse organizations can use existing resources to successfully increase public and healthcare provider awareness about hepatitis B among APIs, promote routine hepatitis B testing and vaccination as part of standard primary care, and ensure access to treatment for chronically infected individuals.
登录
查看更多内容
影响因子:
13.5
作者:
Lin, Steven Y.;Chang, Ellen T.;So, Samuel K.
通讯作者:
So, Samuel K.
影响因子:
25.7
作者:
de Franchis, R;Hadengue, A;Valla, D
通讯作者:
Valla, D
影响因子:
1.4
作者:
Ma, Grace X.;Shive, Steven E.;Khanh, Che
通讯作者:
Khanh, Che
影响因子:
1.9
作者:
Ma, Grace X;Fang, Carolyn Y;Siu, Philip
通讯作者:
Siu, Philip
影响因子:
5.9
作者:
Taylor, VM;Choe, JH;Jackson, JC
通讯作者:
Jackson, JC